The viral vector market is highly active, and the interest in production technologies is driven by recent approvals in cell and gene therapy. In this blog article, insights are shared around the challenges in viral vector manufacturing and how to achieve a scalable and cost-efficient process suitable for GMP manufacturing environments.
Click here to read the article.
